TrialPloS one2020
Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma.
Susan Christine Massey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it